Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Trifluridine and Tipiracil”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Large-scale testing (Phase 3)Ended earlyNCT05223673
What this trial is testing

Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196345
What this trial is testing

TAS-102 Plus Radiotherapy in Elderly ESCC

Who this might be right for
ESCCTAS 102Radiotherapy
Qianfoshan Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT06242067
What this trial is testing

Second-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Hospital of Shandong University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05927857
What this trial is testing

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Who this might be right for
Metastatic Gastric AdenocarcinomaSecond LineChemotherapy
National Health Research Institutes, Taiwan 45
Testing effectiveness (Phase 2)UnknownNCT05266820
What this trial is testing

Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fujian Cancer Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT07270991
What this trial is testing

Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

Who this might be right for
Metastatic Oesogastric Adenocarcinoma
Federation Francophone de Cancerologie Digestive 324
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07071844
What this trial is testing

BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients

Who this might be right for
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 162
Testing effectiveness (Phase 2)Study completedNCT04097028
What this trial is testing

Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8+13 more
Roswell Park Cancer Institute 22
Not applicableStudy completedNCT03665506
What this trial is testing

Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Servier 315
Large-scale testing (Phase 3)Looking for participantsNCT06992648
What this trial is testing

Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer Recurrent
Second Affiliated Hospital, School of Medicine, Zhejiang University 302
Early research (Phase 1)Study completedNCT03317119
What this trial is testing

Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colon CarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Carcinoma+22 more
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT06711471
What this trial is testing

Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
LIN YANG 31
Not applicableStudy completedNCT05839951
What this trial is testing

An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Bayer 818
Testing effectiveness (Phase 2)Study completedNCT03278106
What this trial is testing

TAS-102 in Treating Advanced Biliary Tract Cancers

Who this might be right for
CholangiocarcinomaStage III Gallbladder Cancer AJCC v7Stage IIIA Gallbladder Cancer AJCC v7+4 more
Mayo Clinic 28
Testing effectiveness (Phase 2)Looking for participantsNCT06873763
What this trial is testing

Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)Recurrent Colorectal Cancer
STCube, Inc. 52
Testing effectiveness (Phase 2)Temporarily pausedNCT07011550
What this trial is testing

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Who this might be right for
Microsatellite-stable Colorectal CancerStandard of CareNivolumab+1 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT06485713
What this trial is testing

Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal CancerDrug Therapy
First Affiliated Hospital of Wenzhou Medical University 200
Testing effectiveness (Phase 2)Study completedNCT04059562
What this trial is testing

Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Heinrich-Heine University, Duesseldorf 28
Testing effectiveness (Phase 2)UnknownNCT04660760
What this trial is testing

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+28 more
Academic and Community Cancer Research United 116
Large-scale testing (Phase 3)Looking for participantsNCT07361003
What this trial is testing

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 464
Load More Results